Evidence-based Management of Major Bleeding in Patients Receiving Direct Oral Anticoagulants: An Updated Narrative Review on the Role of Specific Reversal Agents
The indications of direct oral anticoagulants (DOACs) have expanded over the past 15 years. DOACs are effective and safe oral anticoagulants associated with lower bleeding risks and mortality than vitamin K antagonists. However, DOAC users are prone to a considerable bleeding risk, which can occur a...
Main Authors: | Zohair Al Aseri FRCPC EM, CCM, Farjah H. AlGahtani MD, MPH, Majid F. Bakheet MD, Ahmed H. Al-Jedai PharmD, Sarah Almubrik MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-10-01
|
Series: | Journal of Cardiovascular Pharmacology and Therapeutics |
Online Access: | https://doi.org/10.1177/10742484231202655 |
Similar Items
-
Safety of ECT in patients receiving an oral anticoagulant
by: Nicolette R. Centanni, PharmD, BCPS, BCGP, BCPP, et al.
Published: (2021-07-01) -
Evaluation of Patient Characteristics Linked to Major Bleeding Events in Patients Prescribed Direct Oral Anticoagulants
by: Dareen M. Kanaan PharmD, MPH, BCCP, et al.
Published: (2023-05-01) -
External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants
by: FH Rutten, et al.
Published: (2023-04-01) -
Secondary hemosiderosis presented by porphyria cutanea tarda in a kidney dialysis patient: A case report
by: Farjah H AlGahtani, et al.
Published: (2020-02-01) -
Retrospective Analysis of the Real-World Utilization of 4-Factor Prothrombin Complex Concentrate and Plasma in Oral Anticoagulant-Associated Bleeding in US Hospitals
by: Majed A. Refaai MD, et al.
Published: (2023-06-01)